Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: Prognostic significance and clinical implications

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 175-180

  Bellacosa, Alfonso ^a   Almadori, Giovanni ^a   Cavallo, Salvatore ^a   Cadoni, Gabriella ^a   Galli, Jacopo ^a   Ferrandina, Gabriella ^a   Scambia, Giovanni ^a   Neri, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE;

EID: 0030064902     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Million, R. R., Cassisi, N. J., and Clark, J. R. Cancer of the head and neck. In: V. T. De Vita, S. Hellman, and S. A Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp 488-590. Philadelphia: J. B. Lippincott Co., 1989.
2. National Cancer Institute. National Cancer Institute SEER Program 1977-1981. CA Cancer J. Clin., 36: 16-17, 1986.
3. Snow, G B. Cancer of the head and neck region. In: U. Veronesi (ed.), Surgical Oncology, pp. 476-494. New York: Springer-Verlag New York, Inc., 1988.
4. Steal, P. M. Prognosis in laryngeal carcinoma host factors. Clin. Otolaryngol., 15: 111-119, 1990.
5. Stell, P. M. Ploidy in head and neck cancer: a review and metaanalysis. Clin. Otolaryngol., 16: 510-516, 1991.
6. Gusterson, B. A., Anbazhagan, R., Warren, W., Midgely, C., Lane, D. P., O' Hare, M., Stamps, A , Carter, R., and Jayatilake, H. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6: 1785-1789, 1991
7. Anderson, J. A., Irish, J. C., and Ngan, B. Y. Prevalence of RAS oncogene mutation in head and neck carcinoma. J. Otolarynsol., 5: 321-326, 1992.
8. Maurizi, M., Scambia, G., Benedetti Panici, P., Ferrandina, G., Almadori, G., Paludetti, G., De Vincenzo, R., Distefano, M., Brinchi, D., Cadoni, G., and Mancuso, S. EGF receptor expression in primary squamous laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int. J. Cancer, 52: 862-866, 1992.
9. Hishitoya, J., Torijama, M., Oguchi, N., Kitamura, K., Ohshima, M., Asano, K., and Xamamoto, T. Gene amplification and overexpression of EGF receptor in squamous-cell carcinomas of the head and neck. Br. J. Cancer, 59: 559-562, 1989.
10. Lammie, G. A., and Peters, G. Chromosome 11q13 abnormalities in human cancer. Cancer Cells (Cold Spring Harbor), 3: 413-420, 1991.
11. Kitagawa, Y., Ueda, M., Ando, N., Shinozawa, Y., Shimizu, N., and Abe, O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res., 51: 1501-1508, 1991.
12. Mori, M., Tokino, T., Yanagisawa, A., Kanamori, M., Kato, Y., and Nakamura, Y. Association between chromosome 11q13 amplification and prognosis of patients with oesophageal carcinomas. Eur. J. Cancer, 28A: 755-757, 1992.
13. Berenson, J. R., Koga, H., Yang, J., Pearl, J., Holmes, E. C., and Figlin, R. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene, 5: 1343-1348, 1990.
14. Borg, Å., Sigurdsson, H., Clark, G. M., Fernö, M., Fuqua, S. A. W., Olsson, H., Killander, D., and McGurie, W. L. Association of INT2/ HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer, 63: 136-142, 1991.
15. Lammie, G. A , Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6: 439-444, 1991.
16. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B. J. M., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J., and Michalides, R. J. A. M. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52: 5229-5234, 1992.
17. Proctor, A., Coombs, L., Cairns, J., and Knowles, M. Amplification at chromosome 11q13 in transitional cell tumors of the bladder. Oncogene, 6: 789-795, 1991.
18. Zhang, Y., Jiang, W , Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., and Weinstein. I. B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 196: 1010-1016, 1993.
19. Rosenberg, C. L., Kim, H. G., Shows, T. B., Kronenberg, H. M., and Arnold, A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene, 6: 449-453, 1991.
20. Motokura, T., Bloom, T., Kim, H. G., Jüppner, H., Ruderman J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by a bcl1-linked candidate oncogene Nature (Lond.), 350: 512-515, 1991.
21. Withers, D. A., Harvey, R. C., Faust, J. B., Melnyk, O., Carey, K., and Meeker, T. C. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol., 11: 4846-4853, 1991.
22. Schuuring, E., Verhoeven, E., Litvinov, S , and Michalides, R. J. A. M. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol. Cell. Biol., 13: 2891-2898, 1993
23. Bukley, M. F., Sweeney, K J. E., Hamilton, J. A., Sim, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K. W., Musgrove, E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
24. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y-J., Lu, S-H., and Weinstein, I. B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52: 2980-2983, 1992.
25. Jares, P., Fernandez, P. L., Campo, E., Nadal, A , Bosch, F., Aiza, G., Nayach, I , Traserra, J., and Cardesa, A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
26. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
27. Somers, K. D., Cartwright, S. L., and Schechter, G. L. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene, 5: 915-920, 1990.
28. Berenson, J. R., Yang, J., and Mickel, R. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4: 1111-1116, 1989.
29. Volling, P., Jungehulsing, M., Jucker, M., Stutzer, H., Diehl, V., and Tesch, H. Coamplification of the hst-1 and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck. Eur. J. Cancer, 29A: 383-389, 1993.
30. Callender, T., el-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila), 74: 152-158, 1994.
31. Hermanek, P., and Sobin, L. H. Larynx. In: International Union against Cancer. TNM Classification of Malignant Tumors, Ed. 4, pp. 25-28. Berlin: Springer-Verlag, 1992.
32. Ohno, H., Takimoto, G., and McKeithan, T. W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell, 60. 991-997, 1990.
33. Bellacosa, A., Datta, K., Bear, S. E., Patriotis, C., Lazo, P. A., Copeland, N. G., Jenkins, N. A., and Tsichlis, P. N. Effects of provirus integration in the Tpl-1/Ets-1 locus in MoMuLV-induced rat T cell lymphomas. Level of expression, polyadenylation, transcriptional initiation, and differential splicing of the Ets-1 mRNA. J. Virol., 68: 2320-2330, 1994.
34. Jorcyk, C. L., Watson, D. K., Mavrothalassitis, G. J., and Papas, T. S. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene, 6: 523-532, 1991.
35. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
36. Ali, I. U., Campbell, G., Lidereau, R., and Callahan, R. Amplification of c-erbB-2 and aggressive human breast tumors? Science (Wash. DC), 240: 1795-1796, 1988.
37. Kaplan, E., and Meyer, P. Non-parametric estimation from incomplete observation. J Am. Stat. Assoc., 53: 457-481, 1958.
38. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
39. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 34: 197-220, 1972.
40. Van Dyke, D. L., Worsham, M. J., Benninger, M. S., Krause, C. J., Baker, S. R., Wolf, G. T., Drumheller, T , Tilley, B. C., and Carey, T. E. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes & Cancer, 9: 192-206, 1994.
41. Skapek, S. X., Rhee, J., Spicer, D. B., and Lassar, A. B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Wash. DC), 267. 1022-1024, 1995.
42. 1 cyclins. Cell, 73: 1059-1065, 1993.
43. Zhang, S-Y., Klein-Szanto, A. J. P., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.